Harry Trout

Harry Trout, Senior Director of Finance, ENANTA Pharmaceuticals, Inc.  Harry joined ENANTA in 2002 and has more than twenty years of experience as a finance executive in the biotechnology industry. He was instrumental in raising capital through a combination of venture capital, non-dilutive grant funding, collaborations with industry-leading pharmaceutical and biotech companies and debt financings. Most notably, the successful completion of a $56 million Initial Public Offering in March 2013, private equity financings of $100 million, and three collaborations valued at $700 million. Prior to joining ENANTA, Mr. Trout was Vice President and Chief Financial Officer at Focal, Inc., which was acquired by Genzyme in 2002. Earlier in his career, he was a financial consultant working with high tech start-up companies on corporate and business strategy. Mr. Trout serves on the steering committee of the Association of Bioscience Financial Officers and chaired their 2012 National Conference. Mr. Trout has an MBA from  Southern New Hampshire University and a B.S. in Accounting from North Adams State College.